In this video, Yasha S. Modi, MD, discusses end-of-study results for EYP-1901 from EyePoint Pharmaceuticals, a bioerodible, sustained-release intravitreal insert to deliver vorolanib for diabetic ...

Three speakers outlined how AI is likely to have a major impact on the future of preventive cardiology.At the American ...

More than half of adults and more than one-third of children living in the same home as another adult with prediabetes have ...

The American Academy of Orthopaedic Surgeons and the Musculoskeletal Tumor Society have developed a registry that aims to ...

When I attended Franklin & Marshall College in Lancaster, Pennsylvania, I was pre-med mainly for the fun of getting to say, ...

Daily physical activity is effective in reducing risk for heart disease, but a dogmatic 10,000 steps per day goal is not ...

COVID-19 was associated with greater risks for asthma, allergic rhinitis and chronic rhinosinusitis, but risks for these ...

NCX 470 0.1%, a novel nitric oxide-donating bimatoprost eye drop, achieved its primary endpoint in the phase 3 Denali ...

LaShae D. Rolle, MPH, CPH, a national powerlifting champion, went to the gym to train less than 24 hours after receiving her ...

The FDA has approved Wegovy for the treatment of adults with noncirrhotic metabolic dysfunction-associated steatohepatitis ...

People with type 2 diabetes treated with GLP-1 receptor agonists may face a slightly higher risk for eye complications ...

Wearing orthokeratology contact lenses for 11 years led to a substantial reduction in axial length, with a mean treatment ...